The effect of activated platelets on cytokine production by human peripheral blood mononuclear cells (PBMC) was investigated. When PBMC were coincubated with activated autologous platelets amid lipopolysaccharide (LPS, 50-100 pglmL) for 8 h, the production ofinterleukin (IL)-la increased 11-to 18-fold and tumor necrosis factor (TNF)-a 3-to 5-fold compared with PBMC without platelets. Activated platelets in a dual-chamber well that prevented platelet-PBMC contact but permitted passage of soluble factors enhanced IL-la production (P < .01). Platelet-PBMC contact in the chamber resulted in a further enhancement of IL-la production. These data suggest that platelet-PBMC interaction, both directly and with platelet-derived factors, enhances production of shock-producing IL-la and TNF-a, albeit differently. The interaction of platelets with monocytes may play an important role in the pathophysiology of sepsis and disseminated intravascular coagulation.
The effect of activated platelets on cytokine production by human peripheral blood mononuclear cells (PBMC) was investigated. When PBMC were coincubated with activated autologous platelets amid lipopolysaccharide (LPS, 50-100 pglmL) for 8 h, the production ofinterleukin (IL)-la increased 11-to 18-fold and tumor necrosis factor (TNF)-a 3-to 5-fold compared with PBMC without platelets. Activated platelets in a dual-chamber well that prevented platelet-PBMC contact but permitted passage of soluble factors enhanced IL-la production (P < .01). Platelet-PBMC contact in the chamber resulted in a further enhancement of IL-la production. These data suggest that platelet-PBMC interaction, both directly and with platelet-derived factors, enhances production of shock-producing IL-la and TNF-a, albeit differently. The interaction of platelets with monocytes may play an important role in the pathophysiology of sepsis and disseminated intravascular coagulation.
Gram-positive and -negative septicemias remain serious clinical problems that are often complicated by disseminated intravascular coagulation (DIC) [1] [2] [3] . Interleukin (IL)-l and tumor necrosis factor (TNF)-a are key mediators in the pathogenesis and lethality of both types of sepsis [4, 5] . In experimental animals, both IL-l and TNF in the circulation are elevated after injection with either gram-positive or -negative organisms and are considered to be a common pathway resulting in hemodynamic decompensation and mortality [6] . Similar findings have been reported in humans with sepsis, and furthermore, plasma levels of both IL-l (3 and TNF-a can be significantly higher in patients with DIC than without DIC [7, 8] .
We reported that IL-l receptor antagonist (IL-IRa) improved hemodynamic shock in rabbits injected with either Escherichia coli or Staphylococcus epidermidis [9, 10] . We found that the circulating levels of TNF-a in rabbits treated with IL-l Ra in S. epidermidis-induced shock decreased compared with levels in saline-treated animals, suggesting that TNF-a production may be dependent on IL-l induced in an early phase of gram-positive sepsis. In the same model, a dramatic drop in the circulating numbers of platelets was observed in both treatment groups after infusion of S. epidermidis. Thrombocytopenia and neutropenia are frequently observed in septicemia. Hawrylowicz and col-leagues [11, 12] reported that activated platelets express cellassociated IL-l-like activity that is capable of inducing intercellular adhesion molecule 1, IL-6, and granulocyte-macrophage colony-stimulating factor produced by endothelial cells. Another report indicated that activated platelets induce IL-8 secretion by endothelial cells via membrane-associated IL-l activity [12a] . Moreover, activated platelets can interact with monocytes and neutrophils through P-selectin (GMP-140, PADGEM, CD62). P-selectin is stored in a granules of resting platelets as an integral membrane protein and is translocated to the plasma membrane after platelet activation [13] [14] [15] .
Recently, Heddle et al. [16] reported that cytokines generated by leukocytes may be responsible for febrile, nonhemolytic transfusion reactions. These reactions occur in 30% of platelet transfusions and are positively correlated with increased leukocyte contamination [17] . They are observed in 1% of red cell transfusions, even though these have much higher leukocyte concentrations [17] . If platelet-monocyte interactions enhance cytokine production, then this interaction may be involved in the febrile reaction to transfused platelets.
In this study, we investigated in vitro the interaction of platelets with peripheral blood mononuclear cells (PBMC) and their effect on cytokine production in the presence of low concentrations of lipopolysaccharide (LPS), as seen in the circulation of patients with gram-negative sepsis. We also investigated the role of platelets on the synthesis of cytokines by PBMC stimulated with gram-positive S. epidermidis and determined if platelets interacting with monocytes play an important role in shock seen in sepsis and DIC. Platelet isolations. Autologous platelets were prepared from citrate-anticoagulated blood by centrifugation. Briefly, blood anticoagulated with 0.1 vol of citrate anticoagulate (0.04 M citric acid, 0.075 Mtrisodium citrate, 0.14M glucose, pH 4.5) was centrifuged at 180 g for 15 min at room temperature. The platelet-rich plasma (PRP) was collected without disturbing the interface. After adding another 0.1 vol of citrate anticoagulate, the PRP was centrifuged at 1100 g for 10 min at room temperature. The platelet pellet was gently resuspended in 2 mL of TRIS-NaCl-glucose buffer (0.05 M TRIS-HCl [pH 7.4], 0.15 M NaCl, 0.005 M glucose) and then washed twice with TRIS-NaCl-glucose buffer. Platelets were then resuspended in the same ultrafiltered RPMI 1640 medium as above. Both erythrocyte and mononuclear cell contamination in platelet resuspension was <0.1 % as determined by microscopy.
Materials and Methods

Materials
Platelet activation was accessed by FACScan cytometry (Becton Dickinson, San Jose, CA) for P-selectin expression. Isolated platelets in RPMI 1640 were incubated with phycoerythrin-conjugated anti-human P-selectin (Becton Dickinson). During isolation of autologous platelets, storage in RPMI 1640, and incubation (30 min) with anti -P-selectin for cytometry, 25%-30% of the platelets became activated. Addition of thrombin (0.15 U/mL, final concentration) at the time of resuspension of platelets in RPMI 1640 routinely activated 75%-80% ofP-selectin expression by cytometry. P-selectin expression in PRP was only 5%.
PBMe isolation. Blood was collected from healthy volunteers who did not take any medication during the 10 days before phlebotomy. PBMC were separated from heparinized blood (5 U/mL of blood) by centrifugation at 120 g on ficoll-hypaque gradients at room temperature. Cells were washed three times in 0.15 MNaCl, followed by centrifugation at 120 g for 10 min, and were resuspended in ultrafiltered RPMI 1640 containing penicillin (100 U/ mL) and streptomycin (100 J.lg/mL) without serum [18] . Platelet contamination in PBMC suspension was 2-5 platelets/monocyte as determined by phase contrast and confocal microscopy.
Preparation of S. epidermidis. An encapsulated strain of S. epidermidis isolated from a blood culture from a patient with catheter sepsis was prepared as described [6] . S. epidermidis were inoculated into brain-heart infusion broth and propagated at 37°C overnight with shaking. After centrifugation, the S. epidermidis pellet was washed three times with pyrogen-free saline and the organisms were counted; then bacteria were killed by boiling for 30 min. Bacteria were washed six more times with sterile saline and resuspended at 101l/mL in ultrafiltered RPMI 1640 as above. The concentration of bacteria was determined spectrophotometrically and confirmed by direct counting in a Petroff-Hausser bacteria counter. Aliquots of the bacterial suspension were stored at -70°C until used in experiments.
To confirm whether the suspension of S. epidermidis in RPMI 1640 was contaminated with endotoxin, we investigated the effect of polymyxin B on TNF-a production by PBMC stimulated with S. epidermidis (200 bacterialPBMC). LPS (I ng/mL) was used as a positive control. The S. epidermidis suspension and LPS solution were separately preincubated with or without polymyxin B at 5 J.lg/mL for 1 h at room temperature. Then PBMC (1.2 X 10 6 cells/mL, final concentration) were added to these samples and incubated for 8 h. Polymyxin B did not affect TNF-a production by PBMC stimulated with the S. epidermidis, while polymyxin B completely inhibited LPS-induced TNF-a synthesis.
Cell cultures. PBMC (1.2 X 10 6 cells/mL) with or without platelets (5 X 10 8 cells/mL) were incubated with or without a low dose of LPS (50 or 100 pg/mL) or heat-killed S. epidermidis (2 or 200 organisms/PBMC) in sterile polypropylene tubes for 8 h (unless stated otherwise) at 37°C. To ensure strong platelet activation, thrombin (0.15 U/mL) was added to some tubes and compared with non-thrombin-treated cells. The samples in tubes were cultured on a rocking table set at 4 rpm. In some experiments, different numbers of platelets (10 7 , 10 8 , and 10 9 cells/mL) were used. In other experiments, PBMC (1.2 X 10 6 cells/mL, final concentration) and platelets (2 X 10 8 cells/mL, final concentration) were incubated in dual-chamber wells, with the two cell types separated by a filter (Transwell, O.4-J.lm pore size; Costar-Coming), to study the effects of PBMC-platelet cell-to-cell contact and soluble factors released from platelets. Samples in these plates were cultured for 8 h at 37°C in 5% CO 2 • After incubation, all samples were stored at -70°C until assayed for cytokines.
RIA for cytokines. Total IL-1a and TNF-a production by PBMC was determined after three cycles of freeze-thawing [19] . The cytokines were quantitated by specific RIAs as previously reported [19] [20] [21] . The detection limits (95% confidence) of the ILIa and TNF-a RIAs were 80-160 and 40-80 pg/mL, respectively.
Statistical analysis. Results are expressed as mean ± SE of the indicated number of experiments. Data were analyzed by Student's t test for paired samples. Statistical significance was set at P < .05.
Results
Effect ofactivated platelets on IL-l a and TNF-a production by PBMe in the absence of LPS.
To investigate whether thrombin-activated platelets alone induce IL-l a or TNF-a by PBMC, PBMC were incubated without LPS in thy presence of thrombin (0.15 U/mL, final concentration), thrombin-activated platelets, or nonactivated platelets (5 X 10 8 cells/mL, final concentration) for 4, 8, 16 , and 24 h (data not shown). In the absence of LPS, there was no induction of PBMC IL-1a or TNF-a production by thrombin alone or by platelets with or without thrombin. After 16 and 24 h of incubation, there was, however, a small but statistically significant (P < .01) reduction of TNF-a in the presence of thrombin-activated platelets compared with PBMC stimulated by thrombin alone (platelets omitted from incubation). Effect ofactivated platelets on LPS-induced synthesis ofILl a and TNF-a. As shown in figure 1, when PBMC were incubated with platelets activated during isolation or further activated with thrombin (0.15 U/mL) in the absence of LPS for 8 h at 37°C, IL-1a and TNF-a were barely detected. In the absence ofplatelets, PBMC incubated with a low concentration of LPS for 8 h at 37°C produced small amounts of IL-la and TNF-a. When PBMC and thrombin-activated platelets were coincubated in the presence of LPS for 8 h at 37°C, an 11-to 18-fold increase in IL-la and a 3-to 5-fold increase in TNFa were observed compared with results from PBMC incubated with LPS alone.
To ascertain whether 0.15 U/mL thrombin induces IL-la or TNF-a, PBMC were incubated with thrombin in the presence or absence of LPS for 8 h at 37°C. Thrombin (0.15 U/mL) did not affect either IL-la or TNF-a production (figure 1). These results 6 cells/mL) were coincubated with thrombin (0.15 U/mL) or thrombin-activated platelets (5 X 10 8 cells/mL) in absence or presence of LPS at 50 or 100 pg/mL for 8 h at 37°C (n = 4-6). A, With addition of activated platelets, IL-la production was increased ll-fold with LPS at 50 pg/mL and 18-fold with LPS at 100 pg/mL. Addition of non-thrombin-treated platelets (25%-30% activation for P-selectin) increased IL-la production 6-fold with LPS at 50 pg/mL and 14-fold with LPS at 100 pgimL. B, TNF-a production with addition of activated platelets was increased 5-fold with LPS at 50 pg/mL and 3-fold with LPS at 100 pg/mL. Addition ofnon-thrombin-treated platelets increased TNF-a production 3-fold with LPS at 50 and 100 pg/mL. Thrombin did not affect IL-la and TNF-a production by LPS-stimulated PBMC. Data are mean:::!:: SE. Significant differences between cytokine production with or without platelets: * P < .05; *** P < .001, by paired t test.
demonstrate that thrombin-activated platelets, but not thrombin alone, augment the production of IL-la and TNF-a by PBMC stimulated by LPS at low concentrations. Platelets not treated with thrombin, activated 25%-30% for P-selectin expression, enhanced IL-la production 6-to 14-fold and TNF-a production 3-fold when coincubated with PBMC and LPS for 8 h.
Effect of platelets on S. epidermidis-induced synthesis of IL-l a and TNF-a. Thrombin-activated platelets (5 X 10 8 / mL) alone did not induce IL-la or TNF-a production by PBMC incubated in the absence of S. epidermidis, even after 24 h of incubation (data not shown). To investigate whether platelets augment IL-la and TNF-a production by PBMC in the presence of S. epidermidis, PBMC and platelets were coincubated with various concentrations of S. epidermidis (2 or 200 bacterialPBMC) for 8 h at 37°C. As shown in figure 2 , PBMC (1.2 X 10 6 /mL) incubated with platelets (5 X 10 8 /mL) in the presence of 2 S. epidermidis bacteria/PBMC for 8 h induced only minimal IL-l a and TNF-a synthesis.
However, when PBMC and platelets (either strongly activated with thrombin or non-thrombin-treated but activated during isolation) were coincubated in the presence of200 bacteria/PBMC for 8 h at 37°C, IL-la production was enhanced 4-fold with thrombin-activated platelets and 2.7-fold with nonthrombin-activated platelets (from 1610 ± 342 pg/mL to 6514 ± 1058 and 4360 ± 533 pg/mL, respectively; P < .05) compared with IL-la production by PBMC incubated with S. epidermidis without platelets. TNF-a production was enhanced 2.7-fold with thrombin-treated platelets and 2.2-fold with nonthrombin-activated platelets (from 418 ± 80 pg/mL to 941 ± 201 and 1121 ± 241 pg/mL, respectively; P < .05) compared with the production of TNF-a by PBMC incubated with S. epidermidis without platelets.
Effect of platelet concentration on LPS-induced cytokine production by PBMe. We next investigated the effect of the concentration of activated platelets on cytokine production by PBMC stimulated with LPS. When PBMC were incubated with 100 pg/mL LPS, the synthesis ofIL-la in PBMC was increased by activated platelets in a concentration-dependent manner ( figure 3A) . However, in contrast to IL-la, TNF-a production was not enhanced by 10 9 platelets/mL, although a significant increase in TNF-a production was observed with the addition of 10 8 platelets/mL (figure 3B). When PBMC were replaced with MonoMac6 monocytic cells, results similar to those in figure 3 were observed (not shown). Platelets at 10 7 /mL and 108/mL enhanced TNF-a, whereas platelets at 109/mL resulted in decreased TNF-a production.
Effect ofplatelet concentration on S. epidermidis-induced TNF-a production by PBMe. We next investigated the effect of differing numbers of platelets on S. epidermidis (200 bacteria/PBMC)-induced TNF-a synthesis by PBMC. S. epidermidis-induced TNF-a production was augmented by the presence of platelets in a platelet-number-dependent manner (figure 4). Platelets at 10 9 /mL as well as 5 X 10 8 /mL caused 3.0-fold increases in TNF-a production (P < .05). Platelets at ..-..
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.... . PBMC (1.2 X 10 6 /mL) were incubated with or without non-thrombin-activated or thrombin-activated platelets (5 X 10 8 /mL) in presence ofS. epidermidis (2 bacteria/PBMC or 200 bacteria/PBMC) for 8 h at 37°C (n = 6). Addition of non-thrombintreated platelets (25%-30% activation for P-selectin) increased ILIa production 2.7-fold and TNF-a production 2.2-fold with S. epidermidis at 200 bacteria/PBMe. IL-Ia and TNF-a production were enhanced 4.0-fold and 2.7-fold, respectively, by existence of thrombinactivated platelets with S. epidermidis at 200 bacteria/PBMC. Data are mean ± SE. Significant difference between TNF-a production with or without platelets: * P < .05, by paired t test. Figure 3 . Effect of platelet concentration on production of cytokines by peripheral blood mononuclear cells (PBMC). PBMC (10 6 cells/mL), stimulated with lipopolysaccharide (LPS, 100 pg/mL), were incubated with various concentrations of thrombin-activated platelets, producing various ratios of platelets to PBMC (10 7 platelets/ mL, 10: 1; 10 8 platelets/mL, 100: 1; 10 9 platelets/mL, 1000: 1). Significant differences between cytokine production with or without platelets: * P < .05; ** P < .01; *** P < .001, by paired t test. Total IL-l a production increased directly with concentration (ratio) of platelets. IL-la concentration continued to increase with supraphysiologic platelet concentrations (A), while total TNF-a levels decreased with high concentrations (10 9 ) or ratios (1000:1) of platelets (B).
PBMC-platelet contact but allows soluble factors to diffuse between the two chambers. When PBMC and activated platelets were placed in separate chambers, the production of ILl a was significantly increased compared with PBMC with LPS but without platelets (figure 5A). Furthermore, incubation of PBMC with thrombin-activated platelets in the same chamber resulted in greater enhancement of IL-Ia production (P < .0 I). In contrast, thrombin-activated platelets separated by a membrane enhanced the production of TNF-a as much as did incubation of PBMC in direct contact with platelets, although these increases did not reach statistical significance compared with the cells cultured without platelets (figure 5B).
Discussion
In these experiments, the presence of activated platelets greatly enhanced IL-Ia and TNF-a production by PBMC stim-1500 Figure 4 . Platelets enhance TNF-a production in number-dependent manner. Peripheral blood mononuclear cells (PBMC, 1.2 X 10 6 / mL) were incubated with or without different nos. of platelets in absence or presence of Staphylococcus epidermidis at 200 bacterial mL for 8 h (n = 5). Data are mean ± SE. Significant differences between TNF-a production by PBMC stimulated with S. epidermidis with or without platelets: * P < .05, by paired t test.
platelets contain a precursor IL-l that requires a convertase from monocytes to become a detectable form. The effects of platelet-PBMC interactions on LPS-induced TNF-O' production were not as dramatic as on IL-lO' production. The production of TNF-a was enhanced, but not significantly, when PBMC were incubated with activated platelets in dual-chamber culture wells ( figure 5B ). In addition, incubation of PBMC with activated platelets at a concentration of 10 9 cells/mL (yielding a higher ratio of platelets to PBMC than is seen in peripheral blood) did not enhance TNF-O' production, although production of IL-I a was enhanced with high concentrations of platelets ( figure 3A) . Figure 5 . Involvement of soluble mediators released from platelets and platelet-PBMC (peripheral blood mononuclear cell) direct interactions in enhancement of IL-la and TNF-a production. PBMC (1.2 X 10 8 cells/mL) stimulated by 100 pg/mL lipopolysaccharide (LPS) were incubated with thrombin-activated platelets (2 X 10 6 cells/mL) kept separate (S) by membrane or in contact with each other (C) in dual-chamber well (n = 6). A, Both soluble mediators produced by platelets and platelet-PBMC direct contact are involved in enhancement of IL-Ia production seen with addition of platelets. B, TNF-a production in both conditions was not significantly enhanced by platelets. Data are mean ± SE. Significant differences: ** P < .01, by paired t test. ulated with low concentrations ofLPS (50-100 pg/mL) and by S. epidermidis. These results suggest that increases in cytokine production in gram-negative or -positive sepsis might be partly attributable to activated platelets.
In preliminary experiments, platelets incubated for 8 h without thrombin still enhanced LPS-induced PBMC production of IL-lO' and TNF-O'. Over time, isolated platelets are spontaneously activated in RPMI culture medium, which contains calcium. It is well known that calcium plays a central role during platelet activation [22, 23] . Recent studies also show that the interaction of endotoxin with platelets results in changes in the platelet membrane and potentiates the activation of platelets [24, 25] . Furthermore, LPS induces platelet-derived soluble factors that augment the priming effect of LPS on the oxidative response of human polymorphonuclear cells [26] . Staphylococci also activate platelets. Among bacteria, staphylococci are one of the most potent stimuli for platelet activation, and heatkilled staphylococci can activate platelets as much as living organisms [27] .
Our data suggest that cytokine production is enhanced by soluble factors released from platelets and by direct PBMCplatelet interaction. It was recently reported that platelets express cell-associated IL-l bioactivity within minutes of activation [11, 12] . However, when we incubated 10 9 platelets with thrombin and LPS for 8 h at 37°C, then subjected them to three cycles of freeze-thawing, IL-la, IL-l,B, and TNF-O' antigen were undetectable in platelet lysates by our RIAs. The limits of detection for these are~40 pg/mL. In light of other reports of cell-associated IL-l bioactivity expressed by platelets, it may be possible that concentrations of these cytokines were so low that RIA could not detect them, that platelets interfered with the detection of membrane-associated antigens, or that while 10 ng/mL TGF-f3 inhibited the production ofTNF-a [28, 29] . The effects of TGF-f3, stimulatory or inhibitory, depend on the target cell type and the presence of other growth factors [28, 30] . It is possible that low concentrations of TGF-f3 may promote the production ofTNF-a, while higher concentrations of TGF-13 secreted from a larger number of platelets may abolish the effect of some other stimulatory factors produced by platelets.
Another possibility is that the release of proteolytic enzymes by activated platelets may degrade TNF-a in culture medium. Human platelets have several exopeptidases, such as aminopeptidase P, dipeptidyl peptidase IV, carboxypeptidase N, and angiotensin-converting enzyme [31] . It was recently reported that a dipeptidyl peptidase IV-like enzyme on the surface of human monocytic cells participates in TNF-a degradation [32] . Since the majority of monocyte IL-la is intracellular, it would not be accessible to digestion by peptidases released from activated platelets. On the other hand, TNF-a would be degraded because the majority of TNF-a produced by PBMC is secreted. Thus, platelets may regulate cytokine levels not only by enhancing cytokine production but also by accelerating their degradation. Circulating cytokine levels, driven either by endotoxernia or other stimuli, may therefore represent the net of both positive and negative regulatory effects of platelets on monocyte cytokine production. Activated platelets release physiologically important substances in addition to TGF-f3, such as platelet-derived growth factor, platelet-activating factor (PAF), and fibroblast growth factor. It remains to be determined whether other platelet products are associated with these effects on cytokine production. We are currently investigating the identities of the platelet-associated and supernatant modulating factors.
It is critical to note that this dramatic effect of platelets on the production of cytokines is seen in the presence of the low concentrations of LPS seen in the circulation clinically. The concentration of LPS in the circulation of patients with sepsis is generally < 100 pg/mL. Low concentrations of gram-positive staphylococci were also used. Thrombocytopenia is frequently seen in cases of bacterial sepsis in humans and experimental animals. As soon as the vascular endothelium is injured, platelets adhere to the exposed subendothelial surface via glycoprotein Ib receptors [33] , followed by generation of platelet plugs and blood clotting. Platelets are also activated by physiologic stimuli, such as adenosine diphosphate, epinephrine, collagen, or thrombin. Platelets express surface P-selectin minutes after activation, causing adherence with neutrophils and monocytes. Recently, Weyrich et al. [34] reported that activated platelets signal IL-8 and monocyte chemotactic protein-l (MCP-l) production after coincubation with monocytes for 18 h [34] . This signaling is linked to RANTES, PAF, and P-selectin expression on the activated platelets. In this fashion, high concentrations of proinflammatory cytokines (lL-1 a and TNF-a) and chemotactic factors (lL-8 and MCP-l) could be produced locally at the site of inflammation in the presence of gram-negative or -positive bacteria, contributing to tissue damage and organ failure.
Hemostasis is the major physiologic function of platelets. However, if the platelet and cytokine-producing mononuclear ceIVmacrophage interaction described here were selectively inhibited without destroying the ability to produce hemostasis, it might be of benefit in the prevention of organ failure and shock in sepsis and DIC.
